Skip to content

Insider · CIK 0002067635

Emily J. Johns

officer

Files at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp). First filing -, latest -.

In brief

Emily J. Johns files SEC Form 4 as officer at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Emily J. Johns has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 28, 2026NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
AGrant or award
Option to Purchase Common Stockderivative
+12,500$0.00$012,500Aug 28, 2026
Jun 1, 2025NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
AGrant or award
Option to Purchase Common Stockderivative
+500,000$0.00$0500,000Jun 3, 2025

Questions about Emily J. Johns

Answered from the filings on this page, as of the latest one.

Is Emily J. Johns buying or selling?

Emily J. Johns has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Emily J. Johns's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Emily J. Johns has 0.

Where does Emily J. Johns file Form 4?

Emily J. Johns has filed Form 4 at NMTC (NEUROONE MEDICAL TECHNOLOGIES Corp) as Chief Administrative Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Emily J. Johns: insider trades and track record | InsiderTell